Snowball logo
logo
GDTC

CytoMed Therapeutics Limited Ordinary Shares

GDTC β€’ NASDAQ
$0.8653-$0.0609Β  (6.58%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
0.08420.3656040.5091250.06950.3192010.720139
COGS
0.0035010.1090420.0037360.01711.2057651.313529
Gross Profit
0.110291(0.109042)0.5053870.0524(0.886564)(0.593389)
Operating Expenses & Income
Operating Income
(1.156262)(2.283246)(1.57915)(3.130528)(4.51977)(5.586633)
Total Operating Expenses
1.2668572.1742042.0845383.1829083.6332064.993237
R&D Expenses
1.0901751.522181.5940461.9095192.182053.225093
Selling General & Admin Expenses
0.585980.5965060.4570931.2419091.8428180.453738
Earnings from Continuing Operations
Interest Expense
(0.118392)(0.122147)(0.0505)(0.0203)(0.0206)(0.0258)
Interest Income
0.0033690.0020970.2857190.317670.123898-
Income Tax Expense
(0.0534)0.0015990.000653(0.0547)--
Net Income
Net Income
(2.07368)(3.055471)(4.144214)(2.516698)(3.916834)(5.259353)
Supplemental
EBIT
(1.890559)(2.283246)(3.990096)(2.114628)(4.51977)(6.363058)
EBITDA
(1.560681)(1.890379)(3.608948)(1.779265)(4.118186)(5.859661)
In millions of USD, except % and values per 1 share